Trans-resveratrol simultaneously increases cytoplasmic Ca 2+ levels and nitric oxide release in human endothelial cells

Molecular Nutrition and Food Research

Volumn 55, Issue 8, 2011, Pages 1237-1248

  Elíes, Jacobo ^a,b   Cuíñas, Andrea ^a   García Morales, Verónica ^a   Orallo, Francisco ^a   Campos Toimil, Manuel ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Calcium; Endothelial cells; Imaging; Nitric oxide; Resveratrol

Indexed keywords

CALCIUM; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; RESVERATROL; STILBENE DERIVATIVE;

ARTICLE; CELL CULTURE; CYTOPLASM; DRUG ANTAGONISM; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; METABOLISM; PHYSIOLOGY; SECRETION;

AMP-ACTIVATED PROTEIN KINASES; CALCIUM; CELLS, CULTURED; CYTOPLASM; ENDOTHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; STILBENES;

EID: 79961075441     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100240     Document Type: Article

References (55)

1. Siemann, E. H., Creasy, L. L., Concentration of the phytoalexin resveratrol in wine. Am. J. Enol. Vitic. 1992, 43, 49-52.
2. Soleas, G. J., Diamandis, E. P., Goldberg, D. M., Wine as a biological fluid: history, production, and role in disease prevention. J. Clin. Lab. Anal. 1997, 11, 287-313.
3. Ibern-Gómez, M., Roig-Pérez, S., Lamuela-Raventós, R. M., de la Torre-Boronat, M. C., Resveratrol and piceid levels in natural and blended peanut butters. J. Agric. Food Chem. 2000, 48, 6352-6354.
4. Soleas, G. J., Diamandis, E. P., Goldberg, D. M., The world of resveratrol. Adv. Exp. Med. Biol. 2001, 492, 159-182.
5. Bertelli, A. A., Das, D. K., Grapes, wines, resveratrol and heart health. J. Cardiovasc. Pharmacol 2009, 54, 468-476.
6. Campos-Toimil, M., Elíes, J., Orallo, F., in: Singh, V. K., Govil, J. N. (Eds.), Cardiovascular Effects of trans- and cis-Resveratrol. Phytopharmacology and Therapeutic Values III, Vol. 21, Studium Press LLC, Houston, TX, USA 2008, pp. 263-294.
7. Delmas, D., Jannin, B., Latruffe, N., Resveratrol: preventing properties against vascular alterations and ageing. Mol. Nutr. Food Res. 2005, 49, 377-395.
8. Orallo, F., Álvarez, E., Camiña, M., Leiro, J. M. et al., The possible implication of trans-resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol. Pharmacol. 2002, 61, 294-302.
9. Chen, C. K., Pace-Asciak, C. R., Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen. Pharmacol. 1996, 27, 363-366.
10. Orallo, F., Camiña, M., Study of the endothelium-dependent and endothelium-independent vasodilator effects of resveratrol in rat aorta. Br. J. Pharmacol. 1998, 124, 108P.
11. Li, H. F., Tian, Z. F., Qiu, X. Q., Wu, J. X. et al., A study of mechanisms involved in vasodilatation induced by resveratrol in isolated porcine coronary artery. Physiol. Res. 2006, 55, 365-372.
12. Naderali, E. K., Smith, S. L., Doyle, P. J., Williams, G., The mechanism of resveratrol-induced vasorelaxation differs in the mesenteric resistance arteries of lean and obese rats. Clin. Sci. (Lond.) 2001, 100, 55-60.
13. Nagaoka, T., Hein, T. W., Yoshida, A., Kuo, L., Resveratrol, a component of red wine, elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and potassium channels. Invest. Ophthalmol. Vis. Sci. 2007, 48, 4232-4239.
14. Rakici, O., Kiziltepe, U., Coskun, B., Aslamaci, S. et al., Effects of resveratrol on vascular tone and endothelial function of human saphenous vein and internal mammary artery. Int. J. Cardiol. 2005, 105, 209-215.
15. Leblais, V., Krisa, S., Valls, J., Courtois, A. et al., Relaxation induced by red wine polyphenolic compounds in rat pulmonary arteries: lack of inhibition by NO-synthase inhibitor. Fundam. Clin. Pharmacol. 2008, 22, 25-35.
16. Orallo, F., Comparative studies of the antioxidant effects of cis- and trans-resveratrol. Curr. Med. Chem. 2006, 13, 87-98.
17. Schmitt, C. A., Heiss, E. H., Dirsch, V. M., Effect of resveratrol on endothelial cell function: molecular mechanisms. Biofactors 2010, 36, 342-349.
18. Klinge, C. M., Wickramasinghe, N. S., Ivanova, M. M., Dougherty, S. M., Resveratrol stimulates nitric oxide production by increasing estrogen receptor alpha-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells. FASEB J. 2008, 22, 2185-2197.
19. Xu, Q., Hao, X., Yang, Q., Si, L., Resveratrol prevents hyperglycemia-induced endothelial dysfunction via activation of adenosine monophosphate-activated protein kinase. Biochem. Biophys. Res. Commun. 2009, 388, 389-394.
20. Borra, M. T., Smith, B. C., Denu, J. M., Mechanism of human SIRT1 activation by resveratrol. J. Biol. Chem. 2005, 280, 17187-17195.
21. Liu, Z., Zhang, L. P., Ma, H. J., Wang, C. et al., Resveratrol reduces intracellular free calcium concentration in rat ventricular myocytes. Sheng Li Xue. Bao. 2005, 57, 599-604.
22. Zhang, L. P., Yin, J. X., Liu, Z., Zhang, Y. et al., Effect of resveratrol on L-type calcium current in rat ventricular myocytes. Acta Pharmacol. Sin. 2006, 27, 179-183.
23. 2+ handling in A7r5 vascular myocytes. Eur. J. Pharmacol. 2007, 577, 91-99.
24. Campos-Toimil, M., Elíes, J., Orallo, F., Trans- and cis-resveratrol increase cytoplasmic calcium levels in A7r5 vascular smooth muscle cells. Mol. Nutr. Food Res. 2005, 49, 396-404.
25. Fleming, I., Busse, R., Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 284, R1-R12.
26. Kolluru, G. K., Siamwala, J. H., Chatterjee, S., eNOS phosphorylation in health and disease. Biochimie 2010, 92, 1186-1198.
27. 2+ signaling, ERK 1/2 activation, mitogenesis and vasodilator production. J. Endocrinol. 2004, 182, 485-499.
28. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985, 260, 3440-3450.
29. Kojima, H., Nakatsubo, N., Kikuchi, K., Kawahara, S. et al., Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal. Chem. 1998, 70, 2446-2453.
30. Räthel, T. R., Leikert, J. J., Vollmar, A. M., Dirsch, V. M., Application of 4, 5-diaminofluorescein to reliably measure nitric oxide released from endothelial cells in vitro. Biol. Proced. Online 2003, 5, 136-142.
31. Putney, J. W., Capacitative calcium entry: from concept to molecules. Immunol. Rev. 2009, 231, 10-22.
32. +-ATP synthase in the extracellular ATP synthesis and proliferation of human umbilical vein endothelial cells. Mol. Cancer Res. 2003, 1, 931-939.
33. Zini, R., Morin, C., Bertelli, A., Bertelli, A. A. et al., Effects of resveratrol on the rat brain respiratory chain. Drugs Exp. Clin. Res. 1999, 25, 87-97.
34. 2+ antagonist, 8-(N, N-diethylamino)octyl 3, 4, 5-trimethoxybenzoate hydrochloride in smooth and skeletal muscles. Br. J. Pharmacol. 1975, 53, 279-285.
35. Low, A. M., Berdik, M., Sormaz, L., Gataiance, S. et al., Plant alkaloids, tetrandrine and hernandezine, inhibit calcium-depletion stimulated calcium entry in human and bovine endothelial cells. Life Sci. 1996, 58, 2327-2335.
36. 2+ entry. J. Biol. Chem. 2000, 275, 17979-17985.
37. 2+ signaling, TRP channels, and endothelial permeability. Microcirculation 2006, 13, 693-708.
38. Dreher, D., Junod, A. F., Differential effects of superoxide, hydrogen peroxide, and hydroxyl radical on intracellular calcium in human endothelial cells. J. Cell Physiol. 1995, 162, 147-153.
39. 2+signaling pathways. Arterioscler. Thromb. Vasc. Biol. 1998, 18, 1470-1479.
40. Wallerath, T., Deckert, G., Ternes, T., Anderson, H. et al., Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 2002, 106, 1652-1658.
41. Leikert, J. F., Rathel, T. R., Wohlfart, P., Cheynier, V. et al., Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 2002, 106, 1614-1617.
42. Wallerath, T., Li, H., Godtel-Ambrust, U., Schwarz, P. M. et al., A blend of polyphenolic compounds explains the stimulatory effect of red wine on human endothelial NO synthase. Nitric Oxide 2005, 12, 97-104.
43. Zou, J. G., Wang, Z. R., Huang, Y. Z., Cao, K. J. et al., Effect of red wine and wine polyphenol resveratrol on endothelial function in hypercholesterolemic rabbits. Int. J. Mol. Med. 2003, 11, 317-320.
44. Chung, S., Yao, H., Caito, S., Hwang, J. W. et al., Regulation of SIRT1 in cellular functions: role of polyphenols. Arch. Biochem. Biophys. 2010, 501, 79-90.
45. Mannari, C., Bertelli, A. A., Stiaccini, G., Giovannini, L., Wine, sirtuins and nephroprotection: not only resveratrol. Med. Hypotheses 2010, 75, 636-638.
46. 2+ entry and its pharmacological characteristics responsible for endothelium-dependent, NO-mediated relaxation induced by thapsigargin in guinea-pig aorta. J. Pharm. Pharmacol. 1999, 51, 831-840.
47. 2+ ionophore, A23187. Naunyn-Schmiedebergs Arch. Pharmacol. 1999, 360, 69-79.
48. Naderali, E. K., Doyle, P. J., Williams, G., Resveratrol induces vasorelaxation of mesenteric and uterine arteries from female guinea-pigs. Clin. Sci. (Lond.) 2000, 98, 537-543.
49. Buluc, M., Demirel-Yilmaz, E., Resveratrol decreases calcium sensitivity of vascular smooth muscle and enhances cytosolic calcium increase in endothelium. Vascul. Pharmacol. 2006, 44, 231-237.
50. Duarte, J., Andriambeloson, E., Diebolt, M., Andriantsitohaina, R., Wine polyphenols stimulate superoxide anion production to promote calcium signaling and endothelial-dependent vasodilatation. Physiol. Res. 2004, 53, 595-602.
51. Martin, S., Andriambeloson, E., Takeda, K., Andriantsitohaina, R., Red wine polyphenols increase calcium in bovine aortic endothelial cells: a basis to elucidate signalling pathways leading to nitric oxide production. Br. J. Pharmacol. 2002, 135, 1579-1587.
52. Das, D. K., Maulik, N., Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol. Interv. 2006, 6, 36-47.
53. Wang, S., Wang, X., Yan, J., Xie, X. et al., Resveratrol inhibits proliferation of cultured rat cardiac fibroblasts: correlated with NO-cGMP signaling pathway. Eur. J. Pharmacol. 2007, 567, 26-35.
54. Fernández-Morales, J. C., Yánez, M., Orallo, F., Cortès, L. et al., Blockade by nanomolar resveratrol of quantal catecholamine release in chromaffin cells. Mol. Pharmacol. 2010, 78, 734-744.
55. Wong, R. H., Howe, P. R., Buckley, J. D., Coates, A. M. et al., Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure. Nutr. Metab. Cardiovasc. Dis. 2011, in press, DOI: 10.1016/j.numecd.2010.03.003.